GlassScriptPhysician profile
Nicole Kaiser
NPI 1790104412
$201.00
in general payments reported to CMS, 2019-2025
10 companies · $84.71 in 2025
The $84.71 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.72 · 2023: $18.57 · 2025: $84.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.16 | 2019 | |
| Merck Sharp & Dohme LLC | $26.25 | 2019-2025 | Proquad, Rotateq, M-M-R II |
| Amgen INC. | $25.44 | 2019 | |
| Hologic Sales and Service, LLC | $20.35 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Abbott Laboratories | $20.00 | 2025 | Id Now Strep A 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.57 | 2023 | Xifaxan, Trulance |
| Collegium Pharmaceutical, INC. | $16.19 | 2025 | Jornay Pm |
| Novo Nordisk INC | $14.18 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.17 | 2025 | Qelbree |
| Shire North American Group INC | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.